Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by medvic1on Dec 20, 2020 6:10pm
240 Views
Post# 32149906

RE:RE:RE:Management is BORING!!

RE:RE:RE:Management is BORING!!All your points has a merit but please realize one thing about big pharma. Small companies has to stay low and do not claim big progress in anything they try to cure because big pharma afraid possible interruption to their money .., just listen this interview from 3:30 to 21min and understand why the company that has efficacy of their drug 30-40% has a problem to come to the market.  https://www.youtube.com/watch?v=u0oqSJ-tARs

robertshaw wrote:
floatinketucky wrote:
Links6768 wrote: I've been a sharelholder of TLT for a while and have always lurked on these boards but never posted.  After listening to yesterday's presentation I had to post... I'll likely send their IR an email as well.

THESE GUYS ARE BORING... They need a CEO that can get out to the market and tell their exciting and compelling story.  Having these scientists and PhDs as CEOs will only work for investors if they can communicate the excitement and potential of their solution to the general investment community.

This guy Dr Shirazi should be left to the scientific side of the business and leave the investor relations work to somebody else.  

After listening to this guy I also don't see how he can motivate the staff and partners to move forward quickly at the speed they need to move.  The CEO needs to be the person that drives forward the vision of what they're trying to achieve and to motivate all stakeholders along the way to give their left nut for the mission and vision of the organization...

I don't see how this guy has the ability to do that.  We will languish in excuses, mistakes and missed milestones until they have a visionary and true leader at the helm of this ship.

They have THE SOLUTION now let's get this ship moving and get the investor community excited!

His answer to the question give me your top 3 reasons for being an investor in TLT was sooooo unmotivating to me as a shareholder, and i'm sure to any potential investor and to their staff.  He could have had a much more positive and excited response to get all stakeholders interested.


I completly agree. I have said before that he reads like a robot. I was thinking the whole time i was watching both how much more I would rather seen Roger in there. 

And when Shawn was talking to HC Wainwright it was so demotivating. This guy is may be good with dealing with the FDA but his is a sorry sorry sorry spokesman for the company. 

The was some real traction with HC Wainwright's Rep but at every turn Shawn killed the momentum. 
 


It's so miserable for this promising technology under conrol by those idiot management. 7 fu?ing years already.


<< Previous
Bullboard Posts
Next >>